[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Middle East & Africa Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

July 2018 | 100 pages | ID: M1479C7869DEN
Data Bridge Market Research

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Middle East & Africa wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for Middle East & Africa wound care biologics market are listed below:
  • MiMedx
  • WRIGHT MEDICAL GROUP N.V
  • Smith and Nephew
  • INTEGRA LIFE SCIENCES CORPORATION
  • Mölnlycke Health Care AB
  • ConvaTec Inc
The Middle East & Africa wound care biologics market is segmented into:
  • Product Type
  • Wound Type
  • End User
On the basis of product type segment the Middle East & Africa wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the Middle East & Africa wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.

On the basis of wound type the Middle East & Africa wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Middle East & Africa wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user Middle East & Africa wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the Middle East & Africa wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.

Based on geography, the market is segmented into following countries:
  • South Africa
  • Rest of Middle East & Africa
The report covers the present scenario and the growth prospects of the Middle East & Africa wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION

1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Middle East-And Africa Wound Care Biologics Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered

2 MARKET SEGMENTATION

2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.1 Dbmr Market Position Grid
2.2 Dbmr Market Challenge Matrix
2.3 Secondary Sources
2.4 Assumptions

3 MARKET OVERVIEW

3.1 Drivers
  3.1.1 Increasing Cases Of Diabetic Foot Ulcers
  3.1.2 Increasing Incidences Of Burn Cases
  3.1.3 Rising Number Of Geriatric Population
  3.1.4 Innovation In Wound Care Biologics
  3.1.5 New Product Launches
3.2 Restrains
  3.2.1 High Cost Of Wound Treatment And Wound Care Biologics
  3.2.2 Risk Of Skin Substitue Failure
3.3 Opportunities
  3.3.1 3D Skin Printing
  3.3.2 Awareness Programs
3.4 Challenges
  3.4.1 Lack Of Wound Management Services

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Synthetic Skin Grafts
6.3 Growth Factors
  6.3.1 Platelet Derived Growth Factor (Pdgf)
  6.3.2 Platelet Rich Plasma (Prp)
  6.3.3 Epidermal Growth Factors (Egf)
  6.3.4 Basic Fibroblast Growth Factors (Bfgf)
  6.3.5 Granulocyte Colony Stimulating Factor (G-Csf)
  6.3.6 Talactoferrin Alfa
  6.3.7 Thrombin Peptide
  6.3.8 Keratinocy Growth Factor (Kgf)
6.4 Allografts
6.5 Xenografts

7 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE

7.1 Overview
7.2 Wounds
  7.2.1 Surgical Wound
    7.2.1.1 Skin Surgery
      7.2.1.1.1 Wound Closure
      7.2.1.1.2 Skin Biopsy
      7.2.1.1.3 Skin Flap
      7.2.1.1.4 Skin Graft
      7.2.1.1.5 Others
    7.2.1.2 Cosmetic Procedure
      7.2.1.2.1 Brest Enhancement
      7.2.1.2.2 Facial Contouring
      7.2.1.2.3 Facial Rejuvenation:
      7.2.1.2.4 Body Contouring
      7.2.1.2.5 Skin Rejuvenation
      7.2.1.2.6 Others
    7.2.1.3 Gynecologic Procedures
      7.2.1.3.1 Pubovaginalis Sling
      7.2.1.3.2 Pelvic Floor Reconstruction
      7.2.1.3.3 Rectocele Repair Surgery
      7.2.1.3.4 Others
    7.2.1.4 Gastrointestinal Procedure
      7.2.1.4.1 General Gastrointestinal Surgery
      7.2.1.4.2 Hernia
      7.2.1.4.3 Others
  7.2.2 Acute Wounds
  7.2.3 Chronic Wounds
  7.2.4 Traumatic Wounds
7.3 Burns
  7.3.1 Ulcers
  7.3.2 Diabetic Ulcers
  7.3.3 Pressure Ulcer
  7.3.4 Venous Ulcer
  7.3.5 Others

8 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET, BY END USER

8.1 Overview
8.2 Hospitals
8.3 Wound Care Centers
8.4 Ambulatory Surgical Centers
8.5 Clinics
8.6 Community Healthcare Center

9 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET: GEOGRAPHY

9.1 Middle East & Africa
  9.1.1 South Africa
  9.1.2 Rest Of Middle East & Africa

10 MIDDLE EAST-AND AFRICA WOUND CARE BIOLOGICS MARKET, COMPANY LANDSCAPE

10.1 Company Share Analysis: Middle East-And Africa

11 COMPANY PROFILE

11.1 Mimedx.
  11.1.1 Company Overview
  11.1.2 Revenue Analysis:
  11.1.3 Company Share Analysis:
  11.1.4 Product Portfolio
  11.1.5 Recent Developments
11.2 Organogenesis Inc
  11.2.1 Company Overview
  11.2.2 Geographic Presence
  11.2.3 Company Share Analysis:
  11.2.4 Product Portfolio
  11.2.5 Recent Developments
11.3 Integra Lifesciences
  11.3.1 Company Overview
  11.3.2 Revenue Analysis
  11.3.3 Company Share Analysis:
  11.3.4 Product Portfolio
  11.3.5 Recent Developments
11.4 Convatec Inc.
  11.4.1 Company Overview
  11.4.2 Revenue Analysis
  11.4.3 Company Share Analysis:
  11.4.4 Product Portfolio:
  11.4.5 Recent Developments
11.5 Acell Inc.
  11.5.1 Company Overview
  11.5.2 Product Portfolio
  11.5.3 Recent Developments
11.6 Allosource
  11.6.1 Company Overview
  11.6.2 Product Portfolio
  11.6.3 Recent Developments
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc)
  11.7.1 Company Overview
  11.7.2 Product Portfolio
  11.7.3 Recent Developments
11.8 Amnio Technology, Llc
  11.8.1 Company Overview
  11.8.2 Product Portfolio
  11.8.3 Recent Developments
11.9 Amniox Medical, Inc.
  11.9.1 Company Overview
  11.9.2 Product Portfolio
  11.9.3 Recent Developments
11.10 Anika Therapeutics, Inc.
  11.10.1 Company Overview
  11.10.2 Revenue Analysis
  11.10.3 Product Portfolio
  11.10.4 Recent Developments
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.)
  11.11.1 Company Overview
  11.11.2 Geographicpresence
  11.11.3 Product Portfolio
  11.11.4 Recent Developments
11.12 Kerecis
  11.12.1 Company Overview
  11.12.2 Geographical Presence
  11.12.3 Product Portfolio
  11.12.4 Recent Developments
11.13 Marine Polymer Technologies, Inc
  11.13.1 Company Overview
  11.13.2 Product Portfolio
  11.13.3 Recent Developments
11.14 Mölnlycke Health Care Ab
  11.14.1 Company Overview
  11.14.2 Revenue Analysis
  11.14.3 Product Portfolio
  11.14.4 Recent Developments
11.15 Osiris Therapeutics, Inc.
  11.15.1 Company Overview
  11.15.2 Revenue Analysis
  11.15.3 Product Portfolio
  11.15.4 Recent Developments
11.16 Skye Biologics Inc.
  11.16.1 Company Overview
  11.16.2 Product Portfolio:
  11.16.3 Recent Development:
11.17 Smith And Nephew
  11.17.1 Company Overview
  11.17.2 Revenue Analysis
  11.17.3 Product Portfolio
  11.17.4 Recent Developments
11.18 Solsys Medical.
  11.18.1 Company Overview
  11.18.2 Product Portfolio
  11.18.3 Recent Developments
11.19 Vericel Corporation.
  11.19.1 Company Overview
  11.19.2 1.1.2 Revenue Analysis
  11.19.3 Product Portfolio
  11.19.4 Recent Developments
11.20 Wright Medical Group N.V
  11.20.1 Company Overview
  11.20.2 1.1.2 Revenue Analysis
  11.20.3 Product Portfolio
  11.20.4 Recent Developments

12 RELATED REPORTS

LIST OF TABLES

Table 1 Middle East-And Africa Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million)
Table 2 Middle East-And Africa Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 3 Middle East-And Africa Growth Factors In Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million)
Table 4 Middle East-And Africa Growth Factors In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 5 Middle East-And Africa Allografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 6 Middle East-And Africa Xenografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 7 Middle East-And Africa Wound Care Biologics Market, By Wound Type, 2015– 2025 (Usd Million)
Table 8 Middle East-And Africa Wounds In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 9 Middle East-And Africa Wounds In Wound Care Biologics Market, By Wound Type, 2016– 2025 (Usd Million)
Table 10 Middle East-And Africa Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million)
Table 11 Middle East-And Africa Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million)
Table 12 Number Of Cosmetic Surgery, 2016 & 2017
Table 13 Middle East-And Africa Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million)
Table 14 Middle East-And Africa Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million)
Table 15 Middle East-And Africa Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million)
Table 16 Middle East-And Africa Burns In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 17 Middle East-And Africa Ulcers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 18 Middle East-And Africa Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million)
Table 19 Middle East-And Africa Wound Care Biologics Market, By End User, 2016 – 2025 (Usd Million)
Table 20 Middle East-And Africa Hospitals In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 21 Middle East-And Africa Wound Care Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 22 Statistics For Ambulatory Surgical Center. U.S.
Table 23 Middle East-And Africa Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 24 Middle East-And Africa Clinics In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 25 Middle East-And Africa Community Healthcare Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 26 Middle East & Africa Wound Care Biologics Market, By Country, Usd Million (2016-2025)
Table 27 Middle East & Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 28 Middle East & Africa Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 29 Middle East & Africa Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 30 Middle East & Africa Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 31 Middle East & Africa Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 32 Middle East & Africa Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 33 Middle East & Africa Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 34 Middle East & Africa Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 35 Middle East & Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 36 Middle East & Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 37 Middle East & Africa Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 38 South Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 39 South Africa Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 40 South Africa Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 41 South Africa Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 42 South Africa Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 43 South Africa Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 44 South Africa Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 45 South Africa Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 46 South Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 47 South Africa Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 48 South Africa Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 49 Rest Of Middle East & Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)

LIST OF FIGURES

Figure 1 Middle East-And Africa Wound Care Biologics Market: Segmentation
Figure 2 Middle East-And Africa Wound Care Biologics Market: Data Triangulation
Figure 3 Middle East-And Africa Wound Care Biologics Market: Research Snapshot
Figure 4 Middle East-And Africa Wound Care Biologics Market: Bottom Up Approach
Figure 5 Middle East-And Africa Wound Care Biologics Market: Top Down Approach
Figure 6 Middle East-And Africa Wound Care Biologics Market: Interview Demographics
Figure 1 Middle East-And Africa Wound Care Biologics Market: Dbmr Market Position Grid
Figure 2 Middle East-And Africa Wound Care Biologics Market: The Market Challenge Matrix
Figure 3 Drivers, Restraints, Opportunities And Challenges Of Middle East-And Africa Wound Care Biologics Market
Figure 4 Aging Population In Different Countries (2014, 2017 & 2020)
Figure 5 Middle East-And Africa Wound Care Biologics Market: Segmentation
Figure 6 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Middle East-And Africa Wound Care Biologics In The Forecast Period 2018 To 2025
Figure 7 Synthetic Skin Grafts In Middle East-And Africa Wound Care Biologics Is Expected To Account For The Largest Share Of The Middle East-And Africa Wound Care Biologics Market In 2018 & 2025
Figure 8 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Middle East-And Africa Wound Care Biologics Market In The Forecast Period From 2018 To 2025
Figure 9 Worldwide Prevalence Of Various Wound Types, 2011
Figure 10 Cases Of Burn Injuries, (2009 – 2012)
Figure 11 Prevalence Of Pressure Ulcers In Few Countries
Figure 12 Number Of Surgical Procedures And Surgical Site Infections
Figure 13 Middle East-And Africa Wound Care Biologics Market: By Product Type, 2017
Figure 14 Middle East-And Africa Wound Care Biologics Market: By Wound Type, 2017
Figure 15 Middle East-And Africa Wound Care Biologics Market: By End User, Snapshot 2017
Figure 16 Middle East & Africa Wound Care Biologics Market: Snapshot (2017)
Figure 17 Middle East & Africa Wound Care Biologics Market: By Country (2017)
Figure 18 Middle East & Africa Wound Care Biologics Market: By Country (2018 & 2025)
Figure 19 Middle East & Africa Wound Care Biologics Market, By Country (2017 & 2025)
Figure 20 Middle East & Africa Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 21 Middle East-And Africa Wound Care Biologics Market: Company Share 2017 (%)


More Publications